Psoriasis: all 1,928 studies

Page 14 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.

• 12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TENCompletedNCT03511755Not applicable
• A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With PsoriasisCompletedNCT03493269Phase 1
• Ovarian Reserve in Patients With PsoriasisCompletedNCT03492632
• Revitalization of Damaged Skin Due to Chronic Skin DiseasesStatus unknownNCT03485560Early Phase 1
• Resolvin D1 in Psoriasis Before and After Narrowband UVB PhototherapyStatus unknownNCT03483311Not applicable
• Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe PsoriasisStatus unknownNCT03478280Phase 4
• Characterization of Cutaneous Microbiota in the Psoriasis PathogenesisCompletedNCT03475914
• Serum Granulysin Level as a Marker to Detect the Severity of PsoriasisStatus unknownNCT03469219
• A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of PsoriasisCompletedNCT03465696Not applicable
• Identification of New Prognostic Markers in Psoriatic ArthritisCompletedNCT03455166Not applicable
• Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque PsoriasisStatus unknownNCT03453190Phase 4
• Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With CalcipotrieneCompletedNCT03448081Phase 2
• A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in PsoriasisCompletedNCT03445013Phase 1
• Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese SubjectsCompletedNCT03442244Phase 1
• Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis TreatmentCompletedNCT03440541Not applicable
• Safety and Efficacy of UC-MSCs in Patients With Plaque PsoriasisStatus unknownNCT03424629Phase 1
• Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional SkinCompletedNCT03423004Not applicable
• An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male ParticipantsCompletedNCT03419910Phase 1
• Patterns After Administration of MCFAs in Psoriasis and Psoriatic ArthritisCompletedNCT03409211Not applicable
• Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe PsoriasisStatus unknownNCT03408756Phase 4
• A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch TestsCompletedNCT03406117Phase 4
• Body PSOriasis: Long-term Relapse CONTROLCompletedNCT03402828
• Immune Metabolic Associations in Psoriatic ArthritisCompletedNCT03399708
• 1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to MapracoratCompletedNCT03399526Phase 1
• Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe PsoriasisCompletedNCT03392311Phase 1/2
• Psoriatic Inflammation Markers Predictive of Response to AdalimumabCompletedNCT03389984Not applicable
• Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque PsoriasisCompletedNCT03381625Phase 2
• Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous PsoriasisCompletedNCT03374527
• Clinical Study to Investigate Psorax35 Supplementation in Patients With PsoriasisCompletedNCT03359577Not applicable
• The PsoTeenQOL - Preliminary Reliability and ValidityCompletedNCT03358914
• Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in PsoriasisCompletedNCT03348462Phase 4
• Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory DiseasesCompletedNCT03339089
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type PsoriasisCompletedNCT03337022Phase 1
• The Effect of Vitamin D Supplementation on Psoriasis SeverityCompletedNCT03334136Not applicable
• To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp PsoriasisCompletedNCT03331523Phase 3
• Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or LupusCompletedNCT03324919
• Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis VulgarisCompletedNCT03322137Phase 2
• Study to Determine if AZD0284 is Effective and Safe in Treating Plaque PsoriasisTerminatedNCT03310320Phase 1
• Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).Status unknownNCT03307447Phase 4
• Role of Chemokine and Chemokine Receptor in PsoriasisWithdrawnNCT03302390
• Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque PsoriasisWithdrawnNCT03298581Phase 2
• Post-Marketing Surveillance Study of OTEZLACompletedNCT03284879
• Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe PsoriasisCompletedNCT03265613Phase 1/2
• Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail DiseaseStatus unknownNCT03263624Phase 4
• The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female PatientsCompletedNCT03262727Phase 1
• A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet FormulationCompletedNCT03254784Phase 1
• Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)CompletedNCT03253666
• An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric SubjectsActive, not recruitingNCT03240809Phase 4
• A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in ChinaCompletedNCT03236870
• Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.CompletedNCT03231124Phase 1
• Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health ServiceCompletedNCT03223012
• Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate PsoriasisTerminatedNCT03222622Phase 2
• A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT03219437Phase 3
• A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque PsoriasisActive, not recruitingNCT03218488
• MAP Study: Methotrexate and Adalimumab in PsoriasisCompletedNCT03217734Phase 2/3
• GSK2894512 Vehicle-Controlled Study for Adult Plaque PsoriasisWithdrawnNCT03202004Phase 3
• A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult SubjectsWithdrawnNCT03201978Phase 1
• Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin ConditionsTerminatedNCT03198390
• Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic ArthritisStatus unknownNCT03191539Phase 3
• Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque PsoriasisStatus unknownNCT03180866Not applicable
• Assessing Patient Confidence in Biologic MedicationsCompletedNCT03168347Not applicable
• CF101 Therapy in Patients With Moderate-to-severe Plaque PsoriasisCompletedNCT03168256Phase 3
• A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque PsoriasisCompletedNCT03167515Not applicable
• Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of PsoriasisStatus unknownNCT03156062Not applicable
• Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis PatientsCompletedNCT03149900
• Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis PatientsWithdrawnNCT03146247Phase 4
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With PsoriasisTerminatedNCT03145948Phase 1
• A Nurse-led Individualized Educational InterventionStatus unknownNCT03127462Not applicable
• BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp PsoriasisCompletedNCT03122353Phase 1
• Real-World Outcome of Psoriasis Subjects in Korea on AdalimumabCompletedNCT03099083
• A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in BelgiumCompletedNCT03097003
• The Role of Food Sensitivity in PsoriasisCompletedNCT03084146Not applicable
• Enstilar in Combination With Biologic AgentsCompletedNCT03080545Phase 4
• Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/sWithdrawnNCT03079973Phase 3
• The Norwegian Drug Monitoring StudyCompletedNCT03074656Not applicable
• Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque PsoriasisCompletedNCT03069144Phase 1/2
• A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)CompletedNCT03065556Phase 2
• A Study of PRCL-02 in Healthy Volunteers and Plaque PsoriasisCompletedNCT03062618Phase 1
• A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)CompletedNCT03059953
• Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT03058744Phase 1
• Asthma and Atopic Dermatitis Validation of PROMIS Pediatric InstrumentsCompletedNCT03051347Not applicable
• Skin Tape Harvesting for Transcriptomics AnalysisCompletedNCT03048721Not applicable
• Bioavailability of AZD0284 and IV Microtracer StudyCompletedNCT03029741Phase 1
• Biologics Anchoring StudyCompletedNCT03026153Not applicable
• An Exploratory Study to Assess the Efficacy of the Avène HydrotherapyCompletedNCT03023254Not applicable
• Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis SubjectsCompletedNCT03018509Phase 1
• Safety and Pharmacokinetics of Hemay005 In Healthy Male SubjectsCompletedNCT03007810Phase 1
• Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque PsoriasisCompletedNCT03005964Phase 2
• Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male ParticipantsCompletedNCT03004768Phase 1
• Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque TestCompletedNCT03004339Phase 1
• Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type PsoriasisStatus unknownNCT02999776Phase 1
• Patients With Hidradenitis vs Patients With Psoriasis: Psychological ImpactStatus unknownNCT02999698
• Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail PsoriasisCompletedNCT02995473Phase 2
• A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in AdultsWithdrawnNCT02993328Phase 2
• Cardiovascular Risk Evaluation in Psoriasis Treated With PhotochemotherapyCompletedNCT02990624Not applicable
• A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in KoreaCompletedNCT02982005Phase 3
• Insulin Sensitivity, Glucose - and Fat Metabolism in Patients With PsoriasisCompletedNCT02978001
• Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy SubjectsCompletedNCT02976831Phase 1
• A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy VolunteersCompletedNCT02976779Phase 1
• Vasoconstriction Trial With LEO 90100 Aerosol FoamCompletedNCT02973776Phase 1

← Psoriasis overview